Home
This site is intended for healthcare professionals

Global OSA Institute Insights Podcast: Episode 2 Smarter Treatment of OSA

Share

Description

This program is supported by an independent educational grant from Lilly.

Join Dr. Douglas Kirsch for this CME-accredited podcast as he explores how clinicians can move beyond simply prescribing PAP to achieving effective, sustainable control of obstructive sleep apnea (OSA).

Using a real-world patient case, this episode examines practical approaches to troubleshooting PAP, integrating weight and cardiometabolic management, considering emerging treatment options, and coordinating long-term care. Listeners will gain practical strategies for developing a multimodal, patient-centered approach to OSA management.

This is episode two of three, find episodes one and three here.

Who Should Listen?

Primary care physicians and sleep specialists involved in the care of patients with OSA.

This podcast has four segments:

  • Optimizing PAP Therapy – Look beyond the prescription to identify and troubleshoot the barriers preventing effective PAP treatment.
  • Building a Multimodal OSA Plan – Explore why effective OSA care needs to address obesity, cardiometabolic risk, and patient priorities alongside PAP.
  • Exploring Emerging Treatment Options – Consider where anti-obesity pharmacotherapy may fit within an individualized OSA treatment plan.
  • Coordinating Long-Term Care – Discover how shared goals, coordinated follow-up, and multidisciplinary care can turn separate treatments into one integrated plan.

Faculty

Dr Douglas Kirsch is Medical Director of Sleep Medicine at Atrium Health and a Professor of Internal Medicine and Neurology. A board-certified sleep medicine specialist, he has extensive expertise in the diagnosis and management of sleep disorders, with a particular research focus on obstructive sleep apnea. His research examines the impact of OSA treatment on patient hospitalizations and explores the use of consumer wearable devices to assess sleep in the home setting. Dr Kirsch is a former President of the American Academy of Sleep Medicine and is dedicated to improving sleep health and patient well-being.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Dr Douglas Kirsch, faculty for this educational activity, has the following relevant financial relationships: Scientific Advisory Board Apnimed, Incannex, Huxley Medical. Expert Panel Carelon. Consulting ResMed.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Associate Continuing Education

Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 ANCC contact hours.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Fee Information

There is no fee for this educational activity.

This continuing education activity is active starting October 6th 2026, and will expire on July 1st 2028.

Learning objectives

By the end of this Program Learners should be better able to:

Integrate OSA diagnosis into cardiometabolic risk assessment and management through screening of high-risk patients and coordinated cardiometabolic care.

Implement evidence-based, multimodal OSA treatment plans that integrate PAP therapy, cardiometabolic management, and emerging pharmacotherapy, applying a multidisciplinary, chronic-disease model.

Implement simplified, accessible diagnostic algorithms and integrated obesity-CVD-OSA care pathways to overcome diagnostic bottlenecks, reduce care fragmentation, and improve timely access to evidence-based treatment for patients with moderate-to-severe OSA across diverse healthcare settings.

Similar communities

View all

Similar events and on demand videos

Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

Hello and welcome to Global OSA Institute Insights. This episode is titled Spotting OSA Earlier. This independent accredited educational activity is intended for primary care physicians and sleep specialists who care for adults with obstructive sleep apnea. It is supported by an independent educational grant from Lilly. Today we are joined by Doctor Douglas Kirsch, medical director of sleep medicine for Atrium Health and professor at the Wake Forest School of Medicine. Today, we will focus on how a chronic disease multimodal OSA plan can be implemented in the US. Let's start with a case again. A 58-year-old man has severe OSA, obesity, type 2 diabetes, hypertension, and dyslipidemia. Baseline AHI was 38 events per hour with an oxygen nadir of 79%. CPAP was started 6 months ago. He remains sleepy and fatigued with an Epworth Sleepiness scale score of 14. Device download shows average use of 3.1 hours per night, mask leak, dry mouth, and residual AHI of 9 events per hour. BMI is 38 kg per square meter. BP is 154 90 seconds of a millimeter of mercury despite an ARB and calcium channel blocker. HbA1c is 8.3%, 67 moles per mole. LDL cholesterol is 3.2 moles per liter, 124 mg per deciliter. Support has focused on supplying the device. There is no structured weight management or coordinated cardio metabolic plan. Decision point. Is this a Pap problem, a broader chronic disease problem, or both? And what should be done first? Let's turn to Doctor Kirsch again. Before calling this Pap failure, what does the clinician need to establish from the device data, the patient, and the wider sleep history? OK, so this is a patient who, uh, we will say has not been using their CPAP perhaps as effectively as they might otherwise. And there's some problems going on when they use CPAP. And so, let's walk through some of the things that are going on here. One, they're averaging about 3 hours a night, which is not perhaps ideal, but it also means they haven't given up yet. And so in a patient who hasn't given up, how can we make them more successful? Well, some of it may be trying to address the mask leak and the dry mouth, and whether that's a humidifier adjustment for their CPAP, whether that's a new style of mask or perhaps a full face mask. Um, or a better fitting mask in some way. These are things that can help a patient be more successful. The second piece of this is recognizing that the residual AHI is a little bit higher than we might like in somebody who's on a CPAP machine. And that may mean that either the leak is more of a problem than we think it is, um, or it could be that the pressure settings are incorrect. So it's important to start by saying, hey, this patient hasn't failed yet. This patient is trying and maybe more successful if we provide some support and help. What are you gonna do in practice? Well, talk to the patient about what's happening. Why is it only 3 hours a night? Is it that they're falling asleep before they put it on? Or is it they're taking it off in the middle of the night? Um, is there something that's making them take it off? Is it mask discomfort? Is it air pressure? These are things to sort of think through because these are adjustable things that can be changed by the clinician. Now, the other thing that's important to recognize in this case is the patient is not feeling better. And what we don't know is, is that because their sleep apnea is not particularly well controlled yet, possibly, but it's also important to recognize that they have other things going on here, um, from a medical perspective and potentially from a sleep perspective, right? So always knowing, hey, how much sleep are they getting at nighttime? Are they going to bed on time and getting up on time to give them enough sleep? It's not at all uncommon in my practice that even when somebody is adherent to PAP therapy, they may still be sleepy because they're only getting 5 or 6 hours of sleep because of two jobs or because they work on shift work or because of family and childcare. It's important to recognize that there are lots of reasons that people may feel tired during the daytime. Um, so, The thing to recognize here is A, this patient has yet to fail. This patient can still be successful. Um, yes, we generally point towards 4 hours a night as success, but the reality is in my role as a sleep doctor, I'm always trying to get them not just to 4 hours, but to 5 or 6 or 7 hours a night. Some of my most successful patients are using a machine 7 to 8 hours a night. 100% of the time. It is doable with the right guidance and support. We wanna make sure that somebody is using their PAP machine anytime they're sleeping, and whether that's at nighttime or during the daytime. They can be successful, but we need to help them get there. They may not always ask for that support. So, take homes from this one. Review the CPAP data. 2, review the patient and make sure you understand what their symptoms are and what other reasons for their symptoms might exist. And 3, help provide the support to make them more successful on their CPAP machine. Thank you. How would you troubleshoot this patient in a practical sequence over the next few weeks? So that's a great question, and it's pretty common in my practice for someone to show up who is perhaps less than ideally successful on a CPAP machine. So the first thing to do is talk to the patient and understand what the problems are. Is this something that they are uh struggling with for one reason or another? We don't wanna be judgmental. Patients often come in and they're worried that I'm gonna yell at them because they're not using their CPAP machine. And I tell My job isn't to yell at you. My job is to support you to help get you better, and they're often relieved by that. We don't want them to feel like they're failing. We want to help them be successful. So figure out what the problem is and whether that's the mask problem. Which may be combined with a leak problem. Is this a humidification problem? Is this a nasal problem? Is he feeling congested? Are they feeling claustrophobic? There are lots of possible reasons that somebody may find CPAP problematic, but what I'll say here is, one of the things we can do, let's try and adjust the settings on the machine. Perhaps make the pressure a little lower if we can to make them more comfortable, even if it doesn't optimally control their sleep apnea. Let's try and get them a new mask, adjust their humidification, and decide what that next step looks like when we've given them this support. We want to make sure that they feel supported and that we will check on that data, often via remote, uh, monitoring in the next 2 to 4 weeks to see where they're at, and then to reassess and guide at that point. In some cases, we'll need to bring them back into the laboratory to actually titrate them on their CPAP machine to figure out the best pressures. That's usually not a first step, that's usually later in the process, but it is an option, and it may be a time when you can help with mask fitting and or pressure settings and or anything else that may be bothering that patient. In some cases, this may just be a matter of reviewing with the patient why you're using a CPAP machine. It's important to recognize that some patients will have maybe forgotten that they stopped breathing 40 times an hour or that their oxygen got quite low during the night before they got their CPAP machine. They may find it to be a hassle because cleaning is a problem or because uh they feel like their partner is not supportive of the process. Whatever the issues are, trying to address them, check back on the data within a month, and then contact the patient, either continue to support them and say, you're, uh, here, what else can we do to make this more successful? Or conversely, if they're doing really well, Let them know that they're doing really well. People may find it a little silly, but I actually give people gold star stickers in my practice when they're doing well, and you'll be surprised how patients, even older patients, feel somehow a little bit more positive about CPAP when they feel that they've been rewarded for good use. Sticker charts aren't just for little kids sometimes. Even if PAP is optimized, why does this patient still need a multimodal chronic disease plan? So, great. We treated their sleep apnea, their CPAP use looks good, their residual AHI looks good. Fantastic. But it doesn't mean that we've dealt with all of their problems. Clearly, this patient has problems with obesity, with diabetes and hypertension, and their lipids. So, First, at least in my clinic, we are gonna talk about weight because I'm probably not gonna be managing as a sleep doctor their diabetes and hypertension directly. But weight is something I talk about with many patients who come into practice, and this is a modifiable risk factor for sleep apnea. There are obviously a wealth of ways that people can try and work on their weight, whether it be diet, exercise, or pharmacological intervention, but all of those are choices here in a way to help them. And what I'll say is, in the last year, I said this to a patient recently.